Small Pilot Finds More Cardiac Events With Thin-Cap Plaques
Plaque structure may warrant further study alongside coronary disease remaining after treatment, but this small observational pilot does not establish independent predictive value or causation.
Evidence
In a 30-patient heart-attack pilot, serious cardiac events within three months affected 7 of 16 patients (43.8%) with thin-cap plaques, compared with 2 of 14 (14.3%) without them. These plaques, called thin-cap fibroatheromas, have a thin covering over a fatty core. The finding was descriptive; the reported comparisons across four patient groups were not statistically significant.
The study of plaque features and residual coronary disease, published October 26, 2026, was a retrospective observational pilot at a tertiary care center. Researchers screened 142 patients with ST-elevation myocardial infarction, a type of heart attack identified by a characteristic change in the heart’s electrical tracing. Thirty met eligibility criteria and underwent primary percutaneous coronary intervention—an urgent catheter-based procedure to reopen the affected artery.
Researchers examined the culprit lesion, the plaque responsible for the heart attack, using optical coherence tomography, a light-based imaging technique. Thin-cap fibroatheroma was present in 16 patients. They also measured the residual SYNTAX score, which assesses coronary disease remaining after treatment, using final artery images. Patients were divided into four groups by plaque status and a residual score of 4 or less versus above 4.
Overall, 9 of 30 patients (30.0%) experienced a major adverse cardiac event. Across the four groups, event counts were 1 of 7, 1 of 7, 4 of 11 and 3 of 5. Tests comparing event proportions and time to events produced probability values of 0.23 and 0.38, respectively; neither was statistically significant. These tests concerned the four-group comparison, not a separately reported test of the pooled thin-cap versus non-thin-cap comparison.
Analysis
Interpretation: The numerical pattern raises a question about whether plaque structure could add information beyond the amount of coronary disease left after treatment. It does not answer that question. This is a single-study finding, with no independent corroboration here. The observed percentages describe this selected sample; they do not establish that thin-cap plaques independently predict events or cause worse outcomes.
Limitations
Only 30 of 142 screened patients were included, and every subgroup contained fewer than 12 people. Selection bias produced atypical clinical event rates, limiting how well the percentages apply to other heart-attack patients.
No multivariable modeling was performed, so the analysis did not establish whether plaque status predicted outcomes after accounting for other patient characteristics. The nonsignificant tests do not prove that the groups have identical outcomes, but they leave substantial uncertainty around the descriptive differences. The authors characterized the findings as strictly hypothesis-generating.
What to watch
A larger prospective multicenter registry—following patients forward across several centers—could test whether plaque imaging adds independent predictive information. Confidence would increase if it found a higher three-month event risk with thin-cap plaques after accounting for residual disease and other patient characteristics, with an estimate precise enough to exclude no difference.